文献速递腹部介入MR

动态对比增强MRI与体素内不相干运动扩散加权成像评估肝细胞癌对90Y放射性栓塞治疗的反应

Assessment of Hepatocellular Carcinoma Response to 90Y Radioembolization Using Dynamic Contrast Material-enhanced MRI and Intravoxel Incoherent Motion Diffusion-weighted Imaging.
PubMed 文献 · Radiol Imaging Cancer · 2020-07-24

本前瞻性研究纳入24例肝细胞癌患者,于90Y放射性栓塞治疗前及治疗后6周行IVIM DWI和钆塞酸二钠DCE MRI,评估扩散与灌注变化并预测治疗反应。放射性栓塞后灌注显著下降(DCE MRI动脉血流P=0.002,IVIM伪扩散系数D*P=0.014)。基线DCE MRI直方图参数可能有助于放射性栓塞治疗分层。

要点

  • 90Y放射性栓塞后肝细胞癌灌注显著下降:DCE MRI动脉血流P=0.002,IVIM伪扩散系数D*P=0.014。
  • 联合血清甲胎蛋白与门静脉血流Fp偏度预测6周客观反应,AUC=0.924。
  • DCE MRI动脉分数标准差预测6-12个月完全反应,AUC=0.857。

核心结论

  • 扩散与灌注MRI可用于评估肝细胞癌对放射性栓塞的治疗反应。
  • 治疗前DCE MRI直方图参数可能有助于放射性栓塞治疗分层。

研究设计与样本

  • 前瞻性研究(临床试验注册号NCT01871545),经机构审查委员会批准。
  • 纳入24例肝细胞癌患者(平均年龄69岁±9,18例男性),共分析25个病灶(平均大小3.6 cm±1.9)。
  • 治疗前(n=24)及治疗后6周(n=21)行多参数MRI,包括IVIM DWI和钆塞酸二钠DCE MRI。
  • 在肝细胞癌和肝实质中量化IVIM DWI与DCE MRI直方图参数。
  • 采用mRECIST于治疗后6周及6-12个月评估肝细胞癌反应。

关键影像表现/征象

  • 放射性栓塞后灌注显著下降:DCE MRI动脉血流P=0.002,IVIM伪扩散系数D*P=0.014。

诊断标准与关键数值

  • 多变量逻辑回归选择联合血清甲胎蛋白与门静脉血流Fp偏度预测6周客观反应,AUC=0.924。
  • 联合D*标准差与Fp峰度预测6周完全反应,AUC=0.916。
  • DCE MRI参数动脉分数标准差为6-12个月完全反应的最佳预测因子,AUC=0.857。

临床应用与阅片要点

  • DCE MRI与IVIM DWI直方图参数可用于评估肝细胞癌对90Y放射性栓塞的扩散与灌注变化。
  • 基线DCE MRI直方图参数可能有助于放射性栓塞治疗分层。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To quantify diffusion and perfusion changes in hepatocellular carcinoma (HCC) induced by yttrium 90 (90Y) radioembolization and to assess the value of dynamic contrast material-enhanced (DCE) MRI and intravoxel incoherent motion (IVIM) diffusion-weighted imaging (DWI) for predicting HCC response.

MATERIALS AND METHODS: Institutional review board approval was obtained for this prospective study (clinical trial registry NCT01871545). Twenty-four participants with HCC (mean age, 69 years ± 9 [standard deviation], 18 men) underwent multiparametric MRI, including IVIM DWI and gadoxetic acid DCE MRI before (n = 24) and 6 weeks (n = 21) after radioembolization. IVIM DWI and DCE MRI histogram parameters were quantified in HCCs and liver parenchyma. HCC response was assessed by using modified Response Evaluation Criteria in Solid Tumors at 6 weeks and 6-12 months after radioembolization. Logistic regression analysis was used to evaluate the diagnostic performance of baseline MRI and clinical parameters for prediction of response.

RESULTS: Twenty-five HCCs were analyzed (mean size, 3.6 cm ± 1.9). Radioembolization resulted in significantly decreased perfusion (DCE MRI arterial flow, P = .002; IVIM pseudodiffusion coefficient [D*], P = .014). Multivariate logistic regression selected combined serum α-fetoprotein and portal flow (F p ) skewness (area under the curve [AUC] = 0.924) and combined D* standard deviation and F p kurtosis (AUC = 0.916) for prediction of objective and complete response at 6 weeks, respectively. Standard deviation of DCE MRI parameter arterial fraction was selected as the optimal predictor for complete response at 6-12 months (AUC = 0.857).

CONCLUSION: Diffusion and perfusion MRI can be used to evaluate the response of HCC to radioembolization. Pretreatment DCE MRI histogram parameters may be useful for radioembolization treatment stratification. Supplemental material is available for this article. © RSNA, 2020.

来源:Radiol Imaging Cancer,查看原文。版权归原作者所有。

引用

  1. Hectors SJ, Lewis S, Kennedy P, et al. Assessment of Hepatocellular Carcinoma Response to 90Y Radioembolization Using Dynamic Contrast Material-enhanced MRI and Intravoxel Incoherent Motion Diffusion-weighted Imaging. Radiol Imaging Cancer. 2020. PMID: 32803165. doi:10.1148/rycan.2020190094

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。